[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Covid-19 Impact on Intra-Uterine Contraceptive Devices Market, Global Research Reports 2020-2021

June 2020 | 109 pages | ID: C1C280DD27C6EN
QYResearch

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report covers market size and forecasts of Intra-Uterine Contraceptive Devices, including the following market information:
  • Global Intra-Uterine Contraceptive Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
  • Global Intra-Uterine Contraceptive Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
  • Global Intra-Uterine Contraceptive Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
  • Global Intra-Uterine Contraceptive Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players

Major competitors identified in this market include Bayer AG, Teva Pharmaceuticals Industries, Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, Bersil, Amed, etc.

Based on the Region:
  • Asia-Pacific (China, Japan, South Korea, India and ASEAN)
  • North America (US and Canada)
  • Europe (Germany, France, UK and Italy)
  • Rest of World (Latin America, Middle East & Africa)
Based on the Type:
  • Copper IUCD
  • Hormonal IUCD
Based on the Application:
  • Hospitals
  • Gynaecology clinics
  • Community healthcare
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
  1.4.1 Research Process
  1.4.2 Data Triangulation
  1.4.3 Research Approach
  1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
  1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
  1.5.2 Covid-19 Impact: Commodity Prices Indices
  1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Intra-Uterine Contraceptive Devices Industry
1.7 COVID-19 Impact: Intra-Uterine Contraceptive Devices Market Trends

2 GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES QUARTERLY MARKET SIZE ANALYSIS

2.1 Intra-Uterine Contraceptive Devices Business Impact Assessment - COVID-19
  2.1.1 Global Intra-Uterine Contraceptive Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
  2.1.2 Global Intra-Uterine Contraceptive Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Intra-Uterine Contraceptive Devices Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
  2.3.1 Drivers
  2.3.2 Restraints
  2.3.3 Opportunities
  2.3.4 Challenges

3 QUARTERLY COMPETITIVE ASSESSMENT, 2020

3.1 Global Intra-Uterine Contraceptive Devices Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Intra-Uterine Contraceptive Devices Factory Price by Manufacturers
3.3 Location of Key Manufacturers Intra-Uterine Contraceptive Devices Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Intra-Uterine Contraceptive Devices Market
3.5 Key Manufacturers Intra-Uterine Contraceptive Devices Product Offered
3.6 Mergers & Acquisitions, Expansion Plans

4 IMPACT OF COVID-19 ON INTRA-UTERINE CONTRACEPTIVE DEVICES SEGMENTS, BY TYPE

4.1 Introduction
  1.4.1 Copper IUCD
  1.4.2 Hormonal IUCD
4.2 By Type, Global Intra-Uterine Contraceptive Devices Market Size, 2019-2021
  4.2.1 By Type, Global Intra-Uterine Contraceptive Devices Market Size by Type, 2020-2021
  4.2.2 By Type, Global Intra-Uterine Contraceptive Devices Price, 2020-2021

5 IMPACT OF COVID-19 ON INTRA-UTERINE CONTRACEPTIVE DEVICES SEGMENTS, BY APPLICATION

5.1 Overview
  5.5.1 Hospitals
  5.5.2 Gynaecology clinics
  5.5.3 Community healthcare
5.2 By Application, Global Intra-Uterine Contraceptive Devices Market Size, 2019-2021
  5.2.1 By Application, Global Intra-Uterine Contraceptive Devices Market Size by Application, 2019-2021
  5.2.2 By Application, Global Intra-Uterine Contraceptive Devices Price, 2020-2021

6 GEOGRAPHIC ANALYSIS

6.1 Introduction
6.2 North America
  6.2.1 Macroeconomic Indicators of US
  6.2.2 US
  6.2.3 Canada
6.3 Europe
  6.3.1 Macroeconomic Indicators of Europe
  6.3.2 Germany
  6.3.3 France
  6.3.4 UK
  6.3.5 Italy
6.4 Asia-Pacific
  6.4.1 Macroeconomic Indicators of Asia-Pacific
  6.4.2 China
  6.4.3 Japan
  6.4.4 South Korea
  6.4.5 India
  6.4.6 ASEAN
6.5 Rest of World
  6.5.1 Latin America
  6.5.2 Middle East and Africa

7 COMPANY PROFILES

7.1 Bayer AG
  7.1.1 Bayer AG Business Overview
  7.1.2 Bayer AG Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.1.3 Bayer AG Intra-Uterine Contraceptive Devices Product Introduction
  7.1.4 Bayer AG Response to COVID-19 and Related Developments
7.2 Teva Pharmaceuticals Industries
  7.2.1 Teva Pharmaceuticals Industries Business Overview
  7.2.2 Teva Pharmaceuticals Industries Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.2.3 Teva Pharmaceuticals Industries Intra-Uterine Contraceptive Devices Product Introduction
  7.2.4 Teva Pharmaceuticals Industries Response to COVID-19 and Related Developments
7.3 Mona Lisa N.V.
  7.3.1 Mona Lisa N.V. Business Overview
  7.3.2 Mona Lisa N.V. Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.3.3 Mona Lisa N.V. Intra-Uterine Contraceptive Devices Product Introduction
  7.3.4 Mona Lisa N.V. Response to COVID-19 and Related Developments
7.4 DKT International
  7.4.1 DKT International Business Overview
  7.4.2 DKT International Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.4.3 DKT International Intra-Uterine Contraceptive Devices Product Introduction
  7.4.4 DKT International Response to COVID-19 and Related Developments
7.5 Egemen International
  7.5.1 Egemen International Business Overview
  7.5.2 Egemen International Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.5.3 Egemen International Intra-Uterine Contraceptive Devices Product Introduction
  7.5.4 Egemen International Response to COVID-19 and Related Developments
7.6 Melbea AG
  7.6.1 Melbea AG Business Overview
  7.6.2 Melbea AG Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.6.3 Melbea AG Intra-Uterine Contraceptive Devices Product Introduction
  7.6.4 Melbea AG Response to COVID-19 and Related Developments
7.7 Ocon Medical Ltd.
  7.7.1 Ocon Medical Ltd. Business Overview
  7.7.2 Ocon Medical Ltd. Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.7.3 Ocon Medical Ltd. Intra-Uterine Contraceptive Devices Product Introduction
  7.7.4 Ocon Medical Ltd. Response to COVID-19 and Related Developments
7.8 Pregna International Limited
  7.8.1 Pregna International Limited Business Overview
  7.8.2 Pregna International Limited Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.8.3 Pregna International Limited Intra-Uterine Contraceptive Devices Product Introduction
  7.8.4 Pregna International Limited Response to COVID-19 and Related Developments
7.9 Medical Engineering Corporation SA
  7.9.1 Medical Engineering Corporation SA Business Overview
  7.9.2 Medical Engineering Corporation SA Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.9.3 Medical Engineering Corporation SA Intra-Uterine Contraceptive Devices Product Introduction
  7.9.4 Medical Engineering Corporation SA Response to COVID-19 and Related Developments
7.10 SMB Corporation and Meril Life Sciences Pvt. Ltd.
  7.10.1 SMB Corporation and Meril Life Sciences Pvt. Ltd. Business Overview
  7.10.2 SMB Corporation and Meril Life Sciences Pvt. Ltd. Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.10.3 SMB Corporation and Meril Life Sciences Pvt. Ltd. Intra-Uterine Contraceptive Devices Product Introduction
  7.10.4 SMB Corporation and Meril Life Sciences Pvt. Ltd. Response to COVID-19 and Related Developments
7.11 Medu Scientific Ltd, China RH Contraceptives Co., Ltd
  7.11.1 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Business Overview
  7.11.2 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.11.3 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Intra-Uterine Contraceptive Devices Product Introduction
  7.11.4 Medu Scientific Ltd, China RH Contraceptives Co., Ltd Response to COVID-19 and Related Developments
7.12 Sanghai Jolly Medical Education Co., Ltd
  7.12.1 Sanghai Jolly Medical Education Co., Ltd Business Overview
  7.12.2 Sanghai Jolly Medical Education Co., Ltd Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.12.3 Sanghai Jolly Medical Education Co., Ltd Intra-Uterine Contraceptive Devices Product Introduction
  7.12.4 Sanghai Jolly Medical Education Co., Ltd Response to COVID-19 and Related Developments
7.13 Bernstein Leibhard LLP
  7.13.1 Bernstein Leibhard LLP Business Overview
  7.13.2 Bernstein Leibhard LLP Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.13.3 Bernstein Leibhard LLP Intra-Uterine Contraceptive Devices Product Introduction
  7.13.4 Bernstein Leibhard LLP Response to COVID-19 and Related Developments
7.14 Zheijang Daji Medical Instruments, Ltd.
  7.14.1 Zheijang Daji Medical Instruments, Ltd. Business Overview
  7.14.2 Zheijang Daji Medical Instruments, Ltd. Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.14.3 Zheijang Daji Medical Instruments, Ltd. Intra-Uterine Contraceptive Devices Product Introduction
  7.14.4 Zheijang Daji Medical Instruments, Ltd. Response to COVID-19 and Related Developments
7.15 Nimble International
  7.15.1 Nimble International Business Overview
  7.15.2 Nimble International Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.15.3 Nimble International Intra-Uterine Contraceptive Devices Product Introduction
  7.15.4 Nimble International Response to COVID-19 and Related Developments
7.16 AME Line, Technico
  7.16.1 AME Line, Technico Business Overview
  7.16.2 AME Line, Technico Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.16.3 AME Line, Technico Intra-Uterine Contraceptive Devices Product Introduction
  7.16.4 AME Line, Technico Response to COVID-19 and Related Developments
7.17 Cepeo
  7.17.1 Cepeo Business Overview
  7.17.2 Cepeo Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.17.3 Cepeo Intra-Uterine Contraceptive Devices Product Introduction
  7.17.4 Cepeo Response to COVID-19 and Related Developments
7.18 Contraceptivos
  7.18.1 Contraceptivos Business Overview
  7.18.2 Contraceptivos Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.18.3 Contraceptivos Intra-Uterine Contraceptive Devices Product Introduction
  7.18.4 Contraceptivos Response to COVID-19 and Related Developments
7.19 Injeflex Ind And Com Ltda
  7.19.1 Injeflex Ind And Com Ltda Business Overview
  7.19.2 Injeflex Ind And Com Ltda Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.19.3 Injeflex Ind And Com Ltda Intra-Uterine Contraceptive Devices Product Introduction
  7.19.4 Injeflex Ind And Com Ltda Response to COVID-19 and Related Developments
7.20 Bersil
  7.20.1 Bersil Business Overview
  7.20.2 Bersil Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.20.3 Bersil Intra-Uterine Contraceptive Devices Product Introduction
  7.20.4 Bersil Response to COVID-19 and Related Developments
7.21 Amed
  7.21.1 Amed Business Overview
  7.21.2 Amed Intra-Uterine Contraceptive Devices Quarterly Production and Revenue, 2020
  7.21.3 Amed Intra-Uterine Contraceptive Devices Product Introduction
  7.21.4 Amed Response to COVID-19 and Related Developments

8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS

8.1 Intra-Uterine Contraceptive Devices Supply Chain Analysis
  8.1.1 Intra-Uterine Contraceptive Devices Supply Chain Analysis
  8.1.2 Covid-19 Impact on Intra-Uterine Contraceptive Devices Supply Chain
8.2 Distribution Channels Analysis
  8.2.1 Intra-Uterine Contraceptive Devices Distribution Channels
  8.2.2 Covid-19 Impact on Intra-Uterine Contraceptive Devices Distribution Channels
  8.2.3 Intra-Uterine Contraceptive Devices Distributors
8.3 Intra-Uterine Contraceptive Devices Customers

9 KEY FINDINGS

10 APPENDIX

10.1 About Us
10.2 Disclaimer
LIST OF TABLES

Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Intra-Uterine Contraceptive Devices Assessment
Table 9. COVID-19 Impact: Intra-Uterine Contraceptive Devices Market Trends
Table 10. COVID-19 Impact Global Intra-Uterine Contraceptive Devices Market Size
Table 11. Global Intra-Uterine Contraceptive Devices Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Intra-Uterine Contraceptive Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Intra-Uterine Contraceptive Devices Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Intra-Uterine Contraceptive Devices Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Intra-Uterine Contraceptive Devices Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Intra-Uterine Contraceptive Devices Market Growth Drivers
Table 17. Global Intra-Uterine Contraceptive Devices Market Restraints
Table 18. Global Intra-Uterine Contraceptive Devices Market Opportunities
Table 19. Global Intra-Uterine Contraceptive Devices Market Challenges
Table 20. Key Manufacturers Intra-Uterine Contraceptive Devices Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Intra-Uterine Contraceptive Devices Market Size, 2019 (K Units) & (US$ Million)
Table 22. Intra-Uterine Contraceptive Devices Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Intra-Uterine Contraceptive Devices Manufacturing Plants
Table 24. Key Manufacturers Intra-Uterine Contraceptive Devices Market Served
Table 25. Date of Key Manufacturers Enter into Intra-Uterine Contraceptive Devices Market
Table 26. Key Manufacturers Intra-Uterine Contraceptive Devices Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Intra-Uterine Contraceptive Devices Market Size by Type, 2020, (US$ Million)
Table 29. Global Intra-Uterine Contraceptive Devices Market Size by Type, 2020 (K Units)
Table 30. Global Intra-Uterine Contraceptive Devices Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Intra-Uterine Contraceptive Devices Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Intra-Uterine Contraceptive Devices Market Size by Application, 2020-2021 (K Units)
Table 33. Global Intra-Uterine Contraceptive Devices Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Intra-Uterine Contraceptive Devices Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Intra-Uterine Contraceptive Devices Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (K Units)
Table 38. US Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (K Units)
Table 43. Germany Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (K Units)
Table 50. China Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Intra-Uterine Contraceptive Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Bayer AG Business Overview
Table 58. Bayer AG Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Bayer AG Intra-Uterine Contraceptive Devices Product
Table 60. Bayer AG Response to COVID-19 and Related Developments
Table 61. Teva Pharmaceuticals Industries Business Overview
Table 62. Teva Pharmaceuticals Industries Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Teva Pharmaceuticals Industries Intra-Uterine Contraceptive Devices Product
Table 64. Teva Pharmaceuticals Industries Response to COVID-19 and Related Developments
Table 65. Mona Lisa N.V. Business Overview
Table 66. Mona Lisa N.V. Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Mona Lisa N.V. Intra-Uterine Contraceptive Devices Product
Table 68. Mona Lisa N.V. Response to COVID-19 and Related Developments
Table 69. DKT International Business Overview
Table 70. DKT International Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. DKT International Intra-Uterine Contraceptive Devices Product
Table 72. DKT International Response to COVID-19 and Related Developments
Table 73. Egemen International Business Overview
Table 74. Egemen International Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Egemen International Intra-Uterine Contraceptive Devices Product
Table 76. Egemen International Response to COVID-19 and Related Developments
Table 77. Melbea AG Business Overview
Table 78. Melbea AG Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Melbea AG Intra-Uterine Contraceptive Devices Product
Table 80. Melbea AG Response to COVID-19 and Related Developments
Table 81. Ocon Medical Ltd. Business Overview
Table 82. Ocon Medical Ltd. Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Ocon Medical Ltd. Intra-Uterine Contraceptive Devices Product
Table 84. Ocon Medical Ltd. Response to COVID-19 and Related Developments
Table 85. Pregna International Limited Business Overview
Table 86. Pregna International Limited Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Pregna International Limited Intra-Uterine Contraceptive Devices Product
Table 88. Pregna International Limited Response to COVID-19 and Related Developments
Table 89. Medical Engineering Corporation SA Business Overview
Table 90. Medical Engineering Corporation SA Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Medical Engineering Corporation SA Intra-Uterine Contraceptive Devices Product
Table 92. Medical Engineering Corporation SA Response to COVID-19 and Related Developments
Table 93. SMB Corporation and Meril Life Sciences Pvt. Ltd. Business Overview
Table 94. SMB Corporation and Meril Life Sciences Pvt. Ltd. Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. SMB Corporation and Meril Life Sciences Pvt. Ltd. Intra-Uterine Contraceptive Devices Product
Table 96. SMB Corporation and Meril Life Sciences Pvt. Ltd. Response to COVID-19 and Related Developments
Table 97. Medu Scientific Ltd, China RH Contraceptives Co., Ltd Business Overview
Table 98. Medu Scientific Ltd, China RH Contraceptives Co., Ltd Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Medu Scientific Ltd, China RH Contraceptives Co., Ltd Intra-Uterine Contraceptive Devices Product
Table 100. Medu Scientific Ltd, China RH Contraceptives Co., Ltd Response to COVID-19 and Related Developments
Table 101. Sanghai Jolly Medical Education Co., Ltd Business Overview
Table 102. Sanghai Jolly Medical Education Co., Ltd Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Sanghai Jolly Medical Education Co., Ltd Intra-Uterine Contraceptive Devices Product
Table 104. Sanghai Jolly Medical Education Co., Ltd Response to COVID-19 and Related Developments
Table 105. Bernstein Leibhard LLP Business Overview
Table 106. Bernstein Leibhard LLP Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. Bernstein Leibhard LLP Intra-Uterine Contraceptive Devices Product
Table 108. Bernstein Leibhard LLP Response to COVID-19 and Related Developments
Table 109. Zheijang Daji Medical Instruments, Ltd. Business Overview
Table 110. Zheijang Daji Medical Instruments, Ltd. Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Zheijang Daji Medical Instruments, Ltd. Intra-Uterine Contraceptive Devices Product
Table 112. Zheijang Daji Medical Instruments, Ltd. Response to COVID-19 and Related Developments
Table 113. Nimble International Business Overview
Table 114. Nimble International Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 115. Nimble International Intra-Uterine Contraceptive Devices Product
Table 116. Nimble International Response to COVID-19 and Related Developments
Table 117. AME Line, Technico Business Overview
Table 118. AME Line, Technico Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 119. AME Line, Technico Intra-Uterine Contraceptive Devices Product
Table 120. AME Line, Technico Response to COVID-19 and Related Developments
Table 121. Cepeo Business Overview
Table 122. Cepeo Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 123. Cepeo Intra-Uterine Contraceptive Devices Product
Table 124. Cepeo Response to COVID-19 and Related Developments
Table 125. Contraceptivos Business Overview
Table 126. Contraceptivos Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 127. Contraceptivos Intra-Uterine Contraceptive Devices Product
Table 128. Contraceptivos Response to COVID-19 and Related Developments
Table 129. Injeflex Ind And Com Ltda Business Overview
Table 130. Injeflex Ind And Com Ltda Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 131. Injeflex Ind And Com Ltda Intra-Uterine Contraceptive Devices Product
Table 132. Injeflex Ind And Com Ltda Response to COVID-19 and Related Developments
Table 133. Bersil Business Overview
Table 134. Bersil Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 135. Bersil Intra-Uterine Contraceptive Devices Product
Table 136. Bersil Response to COVID-19 and Related Developments
Table 137. Amed Business Overview
Table 138. Amed Intra-Uterine Contraceptive Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 139. Amed Intra-Uterine Contraceptive Devices Product
Table 140. Amed Response to COVID-19 and Related Developments
Table 141. Intra-Uterine Contraceptive Devices Distributors List
Table 142. Intra-Uterine Contraceptive Devices Customers List
Table 143. Covid-19 Impact on Intra-Uterine Contraceptive Devices Customers

LIST OF FIGURES

Figure 1. Intra-Uterine Contraceptive Devices Product Picture
Figure 2. Intra-Uterine Contraceptive Devices Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Intra-Uterine Contraceptive Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Intra-Uterine Contraceptive Devices Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Intra-Uterine Contraceptive Devices Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Intra-Uterine Contraceptive Devices Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Intra-Uterine Contraceptive Devices Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Intra-Uterine Contraceptive Devices Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Intra-Uterine Contraceptive Devices Market Size Market Share, 2019-2021


More Publications